Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-16

FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CANASA (mesalamine) by Allergan, Inc., resulting in updated labeling for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CANASA (Mesalamine)

Snippet

SUPPL AP for CANASA (MESALAMINE)